Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
86.67
-0.93 (-1.06%)
Nov 15, 2024, 12:09 PM EST - Market open
Boston Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,792 | 1,592 | 698 | 1,041 | -82 | 4,700 | Upgrade
|
Depreciation & Amortization | 1,234 | 1,196 | 1,136 | 1,093 | 1,123 | 1,011 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | 22 | -78 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 276 | 58 | 132 | 370 | 533 | 105 | Upgrade
|
Loss (Gain) From Sale of Investments | 71 | 59 | 1 | -250 | -333 | 30 | Upgrade
|
Stock-Based Compensation | 256 | 233 | 220 | 194 | 170 | 157 | Upgrade
|
Other Operating Activities | 150 | 135 | 322 | -149 | 120 | -3,871 | Upgrade
|
Change in Accounts Receivable | -335 | -238 | -220 | -279 | 335 | -130 | Upgrade
|
Change in Inventory | -333 | -660 | -321 | -346 | -65 | -290 | Upgrade
|
Change in Accounts Payable | -119 | 118 | -255 | 408 | -28 | 79 | Upgrade
|
Change in Other Net Operating Assets | -56 | 10 | -209 | -134 | -265 | 45 | Upgrade
|
Operating Cash Flow | 2,936 | 2,503 | 1,526 | 1,870 | 1,508 | 1,836 | Upgrade
|
Operating Cash Flow Growth | 24.78% | 64.02% | -18.40% | 24.01% | -17.86% | 492.26% | Upgrade
|
Capital Expenditures | -780 | -711 | -588 | -554 | -376 | -461 | Upgrade
|
Sale of Property, Plant & Equipment | 1 | 4 | 12 | 14 | 12 | 7 | Upgrade
|
Cash Acquisitions | -2,015 | -1,811 | -1,542 | -2,258 | -3 | -4,382 | Upgrade
|
Divestitures | - | - | 5 | 826 | 15 | 90 | Upgrade
|
Sale (Purchase) of Intangibles | 23 | 30 | 70 | 82 | 87 | 52 | Upgrade
|
Investment in Securities | -264 | -89 | -24 | 279 | -146 | -149 | Upgrade
|
Other Investing Activities | -1 | 3 | 56 | 14 | - | -198 | Upgrade
|
Investing Cash Flow | -3,036 | -2,574 | -2,011 | -1,597 | -411 | -5,041 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 4,161 | 700 | Upgrade
|
Long-Term Debt Issued | - | - | 3,270 | - | 1,683 | 7,229 | Upgrade
|
Total Debt Issued | 2,167 | - | 3,270 | - | 5,844 | 7,929 | Upgrade
|
Short-Term Debt Repaid | - | -4 | -251 | - | -5,583 | -1,575 | Upgrade
|
Long-Term Debt Repaid | - | - | -3,184 | - | -1,260 | -3,560 | Upgrade
|
Total Debt Repaid | -529 | -4 | -3,435 | - | -6,843 | -5,135 | Upgrade
|
Net Debt Issued (Repaid) | 1,638 | -4 | -165 | - | -999 | 2,794 | Upgrade
|
Issuance of Common Stock | 219 | 182 | 136 | 110 | 1,086 | 123 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -535 | - | Upgrade
|
Preferred Dividends Paid | - | -28 | -55 | -55 | -28 | - | Upgrade
|
Dividends Paid | - | -28 | -55 | -55 | -28 | - | Upgrade
|
Other Financing Activities | -242 | -145 | -464 | -150 | -206 | 56 | Upgrade
|
Financing Cash Flow | 1,615 | 5 | -548 | -95 | 293 | 2,973 | Upgrade
|
Foreign Exchange Rate Adjustments | 2 | -4 | -9 | -6 | -2 | 10 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 1 | - | - | Upgrade
|
Net Cash Flow | 1,517 | -70 | -1,042 | 173 | 1,388 | -222 | Upgrade
|
Free Cash Flow | 2,156 | 1,792 | 938 | 1,316 | 1,132 | 1,375 | Upgrade
|
Free Cash Flow Growth | 27.05% | 91.04% | -28.72% | 16.25% | -17.67% | - | Upgrade
|
Free Cash Flow Margin | 13.55% | 12.58% | 7.40% | 11.07% | 11.42% | 12.81% | Upgrade
|
Free Cash Flow Per Share | 1.45 | 1.22 | 0.65 | 0.92 | 0.80 | 0.97 | Upgrade
|
Cash Interest Paid | 259 | 259 | 450 | 338 | 359 | 449 | Upgrade
|
Cash Income Tax Paid | 512 | 512 | 662 | 302 | 207 | 242 | Upgrade
|
Levered Free Cash Flow | 1,805 | 1,880 | 1,155 | 2,654 | 1,110 | 1,402 | Upgrade
|
Unlevered Free Cash Flow | 1,986 | 2,046 | 1,449 | 2,867 | 1,336 | 1,697 | Upgrade
|
Change in Net Working Capital | 515 | 213 | 660 | -912 | 263 | 206 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.